Marjanovic, N. D., Hofree, M., Chan, J. E., Canner, D., Wu, K., Trakala, M., et al. (2020). Emergence of a high-plasticity cell state during lung cancer evolution. Cancer Cell, 38(2), 229–246 e213. https://doi.org/10.1016/j.ccell.2020.06.012
Huang, S. (2021). The logic of cancer treatment: why it is so hard to cure cancer. In B. Strauss et al. (Eds.), Rethinking cancer: A new paradigm for the post-genomics era (pp. 63–128). MIT Press Book.
De Angelis, M. L., Francescangeli, F., La Torre, F., & Zeuner, A. (2019). Stem cell plasticity and dormancy in the development of cancer therapy resistance. Frontiers in Oncology, 9, 626. https://doi.org/10.3389/fonc.2019.00626
Article PubMed PubMed Central Google Scholar
Huang, S. (2021). Reconciling non-genetic plasticity with somatic evolution in cancer. Trends Cancer, 7(4), 309–322. https://doi.org/10.1016/j.trecan.2020.12.007
Article CAS PubMed Google Scholar
Huang, S., & Kauffman, S. (2013). How to escape the cancer attractor: Rationale and limitations of multi-target drugs. Seminars in Cancer Biology, 23(4), 270–278. https://doi.org/10.1016/j.semcancer.2013.06.003
Article CAS PubMed Google Scholar
Chen, J., Li, Y., Yu, T. S., McKay, R. M., Burns, D. K., Kernie, S. G., et al. (2012). A restricted cell population propagates glioblastoma growth after chemotherapy. Nature, 488(7412), 522–526. https://doi.org/10.1038/nature11287
Article CAS PubMed PubMed Central Google Scholar
Kreso, A., O’Brien, C. A., van Galen, P., Gan, O. I., Notta, F., Brown, A. M., et al. (2013). Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer. Science, 339(6119), 543–548. https://doi.org/10.1126/science.1227670
Article CAS PubMed Google Scholar
Roesch, A., Fukunaga-Kalabis, M., Schmidt, E. C., Zabierowski, S. E., Brafford, P. A., Vultur, A., et al. (2010). A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell, 141(4), 583–594. https://doi.org/10.1016/j.cell.2010.04.020
Article CAS PubMed PubMed Central Google Scholar
Shaffer, S. M., Dunagin, M. C., Torborg, S. R., Torre, E. A., Emert, B., Krepler, C., et al. (2017). Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance. Nature, 546(7658), 431–435. https://doi.org/10.1038/nature22794
Article CAS PubMed PubMed Central Google Scholar
Dembinski, J. L., & Krauss, S. (2009). Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma. Clinical & Experimental Metastasis, 26(7), 611–623. https://doi.org/10.1007/s10585-009-9260-0
Ebinger, S., Ozdemir, E. Z., Ziegenhain, C., Tiedt, S., Castro Alves, C., Grunert, M., et al. (2016). Characterization of rare, dormant, and therapy-resistant cells in acute lymphoblastic leukemia. Cancer Cell, 30(6), 849–862. https://doi.org/10.1016/j.ccell.2016.11.002
Article CAS PubMed PubMed Central Google Scholar
Francescangeli, F., Contavalli, P., De Angelis, M. L., Careccia, S., Signore, M., Haas, T. L., et al. (2020). A pre-existing population of ZEB2(+) quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer. Journal of Experimental & Clinical Cancer Research, 39(1), 2. https://doi.org/10.1186/s13046-019-1505-4
Holtz, M. S., Forman, S. J., & Bhatia, R. (2005). Nonproliferating CML CD34+ progenitors are resistant to apoptosis induced by a wide range of proapoptotic stimuli. Leukemia, 19(6), 1034–1041. https://doi.org/10.1038/sj.leu.2403724
Article CAS PubMed Google Scholar
Pece, S., Tosoni, D., Confalonieri, S., Mazzarol, G., Vecchi, M., Ronzoni, S., et al. (2010). Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell, 140(1), 62–73. https://doi.org/10.1016/j.cell.2009.12.007
Article CAS PubMed Google Scholar
Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., et al. (2010). A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell, 141(1), 69–80. https://doi.org/10.1016/j.cell.2010.02.027
Article CAS PubMed PubMed Central Google Scholar
Zeuner, A., Francescangeli, F., Contavalli, P., Zapparelli, G., Apuzzo, T., Eramo, A., et al. (2014). Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer. Cell Death and Differentiation, 21(12), 1877–1888. https://doi.org/10.1038/cdd.2014.105
Article CAS PubMed PubMed Central Google Scholar
Zowada, M. K., Tirier, S. M., Dieter, S. M., Krieger, T. G., Oberlack, A., Chua, R. L., et al. (2021). Functional states in tumor-initiating cell differentiation in human colorectal cancer. Cancers (Basel), 13(5), 1097. https://doi.org/10.3390/cancers13051097
Rainusso, N., Man, T.-K., Lau, C. C., Hicks, J., Shen, J. J., Yu, A., et al. (2011). Identification and gene expression profiling of tumor-initiating cells isolated from human osteosarcoma cell lines in an orthotopic mouse model. Cancer Biology & Therapy, 12(4), 278–287.
Gao, M. Q., Choi, Y. P., Kang, S., Youn, J. H., & Cho, N. H. (2010). CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells. Oncogene, 29(18), 2672–2680. https://doi.org/10.1038/onc.2010.35
Article CAS PubMed Google Scholar
Lennon, J. T., den Hollander, F., Wilke-Berenguer, M., & Blath, J. (2021). Principles of seed banks and the emergence of complexity from dormancy. Nature Communications, 12(1), 4807. https://doi.org/10.1038/s41467-021-24733-1
Article CAS PubMed PubMed Central Google Scholar
Endo, H., & Inoue, M. (2019). Dormancy in cancer. Cancer Science, 110(2), 474–480.
Article CAS PubMed PubMed Central Google Scholar
Recasens, A., & Munoz, L. (2019). Targeting cancer cell dormancy. Trends in Pharmacological Sciences, 40(2), 128–141. https://doi.org/10.1016/j.tips.2018.12.004
Article CAS PubMed Google Scholar
Baldominos, P., Barbera-Mourelle, A., Barreiro, O., Huang, Y., Wight, A., Cho, J. W., et al. (2022). Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche. Cell, 185(10), 1694-1708 e1619. https://doi.org/10.1016/j.cell.2022.03.033
Article CAS PubMed Google Scholar
Fluegen, G., Avivar-Valderas, A., Wang, Y., Padgen, M. R., Williams, J. K., Nobre, A. R., et al. (2017). Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments. Nature Cell Biology, 19(2), 120–132. https://doi.org/10.1038/ncb3465
Article CAS PubMed PubMed Central Google Scholar
Ohta, Y., Fujii, M., Takahashi, S., Takano, A., Nanki, K., Matano, M., et al. (2022). Cell-matrix interface regulates dormancy in human colon cancer stem cells. Nature, 608(7924), 784–794. https://doi.org/10.1038/s41586-022-05043-y
Article CAS PubMed Google Scholar
Xie, X. P., Laks, D. R., Sun, D., Ganbold, M., Wang, Z., Pedraza, A. M., et al. (2022). Quiescent human glioblastoma cancer stem cells drive tumor initiation, expansion, and recurrence following chemotherapy. Developmental Cell, 57(1), 32-46 e38. https://doi.org/10.1016/j.devcel.2021.12.007
Article CAS PubMed PubMed Central Google Scholar
Harper, K. L., Sosa, M. S., Entenberg, D., Hosseini, H., Cheung, J. F., Nobre, R., et al. (2016). Mechanism of early dissemination and metastasis in Her2(+) mammary cancer. Nature, 540(7634), 588–592. https://doi.org/10.1038/nature20609
Article CAS PubMed PubMed Central Google Scholar
Hu, Z., Ding, J., Ma, Z., Sun, R., Seoane, J. A., Scott Shaffer, J., et al. (2019). Quantitative evidence for early metastatic seeding in colorectal cancer. Nature Genetics, 51(7), 1113–1122. https://doi.org/10.1038/s41588-019-0423-x
Article CAS PubMed PubMed Central Google Scholar
Lawson, D. A., Bhakta, N. R., Kessenbrock, K., Prummel, K. D., Yu, Y., Takai, K., et al. (2015). Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells. Nature, 526(7571), 131–135. https://doi.org/10.1038/nature15260
Article CAS PubMed PubMed Central Google Scholar
Risson, E., Nobre, A. R., Maguer-Satta, V., & Aguirre-Ghiso, J. A. (2020). The current paradigm and challenges ahead for the dormancy of disseminated tumor cells. Nature Cancer, 1(7), 672–680. https://doi.org/10.1038/s43018-020-0088-5
Article CAS PubMed PubMed Central Google Scholar
Aguirre-Ghiso, J. A. (2021). Translating the science of cancer dormancy to the clinic. Cancer Research, 81(18), 4673–4675. https://doi.org/10.1158/0008-5472.CAN-21-1407
Article CAS PubMed PubMed Central Google Scholar
Shepherd, T. G., & Dick, F. A. (2022). Principles of dormancy evident in high-grade serous ovarian cancer. Cell Division, 17(1), 2. https://doi.org/10.1186/s13008-022-00079-y
Article PubMed PubMed Central Google Scholar
Prager, B. C., Bhargava, S., Mahadev, V., Hubert, C. G., & Rich, J. N. (2020). Glioblastoma stem cells: Driving resilience through chaos. Trends Cancer, 6(3), 223–235. https://doi.org/10.1016/j.trecan.2020.01.009
Article PubMed PubMed Central Google Scholar
Maynard, A., McCoach, C. E., Rotow, J. K., Harris, L., Haderk, F., Kerr, D. L., et al. (2020). Therapy-induced evolution of human lung cancer revealed by single-cell RNA sequencing. Cell, 182(5), 1232–1251 e1222. https://doi.org/10.1016/j.cell.2020.07.017
De Angelis, M. L., Francescangeli, F., & Zeuner, A. (2019). Breast cancer stem cells as drivers of tumor chemoresistance, dormancy and relapse: New challenges and therapeutic opportunities. Cancers (Basel), 11(10), 1569. https://doi.org/10.3390/cancers11101569
Huang, S. (2021). The logic of cancer treatment: treatment-induced progression, hyper-progression, and the Nietzsche effect. In B. Strauss, M. Bertolaso, I. Ernberg, & M. J. Bissell (Eds.), Rethinking Cancer: A New Paradigm for the Postgenomics Era (pp. 62): The MIT Press.
Goddard, E. T., Bozic, I., Riddell, S. R., & Ghajar, C. M. (2018). Dormant tumour cells, their niches and the influence of immunity. Nature Cell Biology, 20(11), 1240–1249.
留言 (0)